Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

The role of health-related quality of life in early discontinuation of chemotherapy for breast cancer.

The role of health-related quality of life in early discontinuation of chemotherapy for breast cancer. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • The role of health-related quality of life in early discontinuation of chemotherapy for breast cancer. Abstract Text:

    lisa c richardsonLisa C Richardson,wei wangWei Wang,abraham g hartzemaAbraham G Hartzema,samuel wagnerSamuel Wagner,lisa c richardsonLisa C Richardson,wei wangWei Wang,abraham g hartzemaAbraham G Hartzema,samuel wagnerSamuel Wagner,

    To examine the role of health-related quality of life (HRQOL) in early treatment discontinuation among women enrolled in a breast cancer clinical trial. A total of 464 women were enrolled in the Eastern Cooperative Oncology Group randomized controlled trial of adjuvant regimens comparing six cycles of cytoxan, adriamycin and 5-flurouricil (5-FU) with a 16-week regimen (weekly therapy with cytoxan, adriamycin, vincristine, methotrexate, and 5-FU) among women with lymph node positive breast cancer. One hundred sixty-four women participated in the HrQL substudy using the Breast Chemotherapy Questionnaire, which was designed to measure HRQOL in women receiving chemotherapy. Changes in global HRQOL score were examined over time as a predictor of early treatment discontinuation using generalized estimation equations (GEE) modeling and Cox proportional hazards regression. We considered early treatment discontinuation as a longitudinal binary variable determined at each time point HRQOL was measured. The results of multivariate GEE model fitting indicated that declines in HRQOL (p=0.04), older age (p=0.02), higher degree of nausea (p=0.02), higher degree of neurosensory toxicity (0.03) and lower degrees of hair loss (p=0.004) were correlated with early treatment discontinuation. We then fitted a proportional hazard regression model for time to early discontinuation with HRQOL score as a time-dependent covariate. The results were identical. Declines in HRQOL during therapy predicted early treatment discontinuation even after accounting for age and chemotherapy-related side effects. In the age of ever more aggressive treatments for breast cancer, women's perception of the impact of these treatments on their lives will become more important.

    The role of health-related quality of life in early discontinuation of chemotherapy for breast cancer. Publishing Authors By Initials

    lc richardsonLC Richardson,w wangW Wang,ag hartzemaAG Hartzema,s wagnerS Wagner,lc richardsonLC Richardson,w wangW Wang,ag hartzemaAG Hartzema,s wagnerS Wagner,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    The role of health-related quality of life in early discontinuation of chemotherapy for breast cancer. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: The breast journal

    VOLUME: 13

    Page Numbers: 581-7

    Journal Abbreviation:

    ISSN: 1075-122X

    DAY: 6

    MONTH: 11

    YEAR: 2007

    The role of health-related quality of life in early discontinuation of chemotherapy for breast cancer. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9505539

    The role of health-related quality of life in early discontinuation of chemotherapy for breast cancer. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: The role of health-related quality of life in early discontinuation of chemotherapy for breast cancer. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for The role of health-related quality of life in early discontinuation of chemotherapy for breast cancer.

    AFFILIATION: Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA. lfr8@cdc.gov

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Breast J

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    The role of health-related quality of life in early discontinuation of chemotherapy for breast cancer Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News